SCHEMBL4109596

SCHEMBL4109596

COc1cccc(C(=O)c2cc(Cl)ccc2-n2ccc(C=C(C)C)c2)c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 12/20 0.41
TUBB P07437 12/20 0.41
TUBA3C P0DPH7 12/20 0.41
TUBA1B P68363 12/20 0.41
TUBA4A P68366 12/20 0.41
TUBB4B P68371 12/20 0.41
TUBB3 Q13509 12/20 0.41
TUBB2A Q13885 12/20 0.41
TUBB8 Q3ZCM7 12/20 0.41
TUBA3E Q6PEY2 12/20 0.41
TUBA1A Q71U36 12/20 0.41
TUBA1C Q9BQE3 12/20 0.41
TUBB6 Q9BUF5 12/20 0.41
TUBB2B Q9BVA1 12/20 0.41
TUBB1 Q9H4B7 12/20 0.41
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111889 0.90 TUBB4A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4122687 0.83 L3MBTL1 (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4110749 0.83 GAA (0.39)
SCHEMBL4132642 0.83 FNTA (0.39) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL13775477 0.82 FNTA (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL13775453 0.80 TUBB4A (0.41) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4121572 0.79 KDM4E (0.35) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL4121567 0.79 KDM4E (0.35) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL13775474 0.78 FNTA (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL13775798 0.78 CYP19A1 (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR TUBB4A 4303/4885TUBB 3846/4885TUBA3C 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.